Skip to content

Konjac oligosaccharide on the gut microbiome in overweight during intermittent fasting

Konjac oligosaccharide on the gut microbiome in overweight during intermittent fasting

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200058139
Enrollment
Unknown
Registered
2022-03-30
Start date
2022-04-01
Completion date
Unknown
Last updated
2023-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

obesity and its related metabolic disorders

Interventions

Intermittent fasting:
Intermittent fasting & Konjac oligosaccharide:
Control group:NO
Control group & Konjac oligosaccharide:

Sponsors

Northwest Minzu University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1.18-65 years (including the critical value), no gender limitation; 2.BMI 25 or greater; 3.One can understand the procedures and methods of this study, be willing to strictly abide by the clinical trial protocol to complete this trial, and voluntarily sign an informed consent.

Exclusion criteria

Exclusion criteria: 1. Have not used antibiotics, prebiotics and probiotics for at least one month; 2. Known or suspected allergic constitution; 3. Various secondary hypertension syndromes (including renal parenchymal, renal vascular hypertension, endocrine and sleep apnea syndrome, etc.); 4. No autoimmune diseases such as lupus erythematosus and rheumatoid arthritis; 5. Other chronic diseases except metabolic syndrome (cirrhosis, chronic nephritis and tumors in other parts); 6. Have received coronary stent implantation in the past (i.e., cardiac stent surgery); 7. Complicated with tumor or previous tumor history or other major diseases of digestive, respiratory, blood and other systems; 8. Those who are prone to alcoholism or drug abuse or addiction; 9. Persons with other serious nervous and mental system diseases who are unable to cooperate or unwilling to cooperate to complete the prescribed examination items, or who are accompanied with suicidal tendencies; 10. Pregnant or lactating women or those who have a recent birth plan; 11. It is accompanied with obvious oral diseases, such as caries, periodontal diseases, mucosal related diseases, etc; 12. Those who have participated in other clinical researches; 13. Other situations that the investigator considers inappropriate to participate in this test.

Design outcomes

Primary

MeasureTime frame
Gut microbiota;Fecal metabolome;Serum metabolome;Oral microorganism;Urine metabolome;

Secondary

MeasureTime frame
Other blood parameters;Other urine parameters;Body composition;

Countries

China

Contacts

Public ContactJunhong Su

Northwest Minzu University

junhong_su@163.com+86 13529225921

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026